Role of connexin-43 in protective PI3K-AKT-GSK-3β signaling in cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 12, 2012, Pages 2536-2544

  Ishikawa, Satoko ^a   Kuno, Atsushi ^a   Tanno, Masaya ^a   Miki, Takayuki ^a   Kouzu, Hidemichi ^a   Itoh, Takahito ^a   Sato, Tatsuya ^a   Sunaga, Daisuke ^a   Murase, Hiromichi ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

G protein coupled receptor; Glycogen synthase kinase 3 ; Insulin like growth fac tor 1; Mitochondria; Phosphoinositide 3 kinase; Reactive oxygen species

Indexed keywords

ANTIMYCIN A1; CONNEXIN 43; DIAZOXIDE; ENDOTHELIN 1; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GLYCOGEN SYNTHASE KINASE 3BETA; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; RECOMBINANT SOMATOMEDIN C; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; ATTENUATION; CELL DEATH; CELL LINE; CELL PROTECTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CELL; HEART PROTECTION; HYPOTHESIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; CELL LINE; CONNEXIN 43; CYTOPROTECTION; ENDOTHELIN-1; ENKEPHALIN, LEUCINE-2-ALANINE; GAP JUNCTIONS; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; MITOCHONDRIA; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84862586662     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00940.2011     Document Type: Article

References (40)

1. Ai X, Zhao W, Pogwizd SM. Connexin43 knockdown or overexpression modulates cell coupling in control and failing rabbit left ventricular myocytes. Cardiovasc Res 85: 751-762, 2010.
2. Alcoléa S, Théveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzoua-nacou E, Chauvin JP, Briand JP, Moorman AF, Lamers WH, Gros DB. Downregulation of connexin 45 gene products during mouse heart development. Circ Res 84: 1365-1379, 1999.
3. Bao M, Kanter EM, Huang RY, Maxeiner S, Frank M, Zhang Y, Schuessler RB, Smith TW, Townsend RR, Rohrs HW, Bethoud VM, Willecke K, Laing JG, Yamada KA. Residual Cx45 and its relationship to Cx43 in murine ventricular myocardium. Channels 5: 489-499, 2011.
4. Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, Schulz R. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol 104: 141-147, 2009.
5. Boulaksil M, Winckels SK, Engelen MA, Stein M, van Veen TA, Jansen JA, Linnenbank AC, Bierhuizen MF, Groenewegen WA, van Oosterhout MF, Kirkels JH, de Jonge N, Varró A, Vos MA, de Bakker JM, van Rijen HV. Heterogeneous connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail 12: 913-921, 2010.
6. Budas GR, Sukhodub A, Alessi DR, Jovanović A. 3=Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. FASEB J 20: 2556-2558, 2006.
7. Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH, Nattel S. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res 105: 1213-1222, 2009.
8. Chaytor AT, Martin PEM, Edwards DH, Griffith TM. Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. Am J Physiol Heart Circ Physiol 280: H2441-H2450, 2001.
9. Decrock E, Vinken M, De Vuyst E, Krysko DV, D'Herde K, Vanhaecke T, Vandenabeele P, Rogiers V, Leybaert L. Connexin-related signaling in cell death: to live or let die? Cell Death Differ 16: 524-536, 2009.
10. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-58, 2007.
11. Förster K, Paul I, Solenkova N, Staudt A, Cohen MV, Downey JM, Felix SB, Krieg T. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol 101: 319-326, 2006.
12. Fortes FS, Pecora IL, Persechini PM, Hurtado S, Costa V, Coutinho-Silva R, Braga MB, Silva-Filho FC, Bisaggio RC, De Farias FP, Scemes E, De Carvalho AC, Goldenberg RC. Modulation of intercellular communication in macrophages: possible interactions between GAP junctions and P2 receptors. J Cell Sci 117: 4717-4726, 2004.
13. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 62: 233-245, 2004.
14. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-966, 2004.
15. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, García-Dorado D, Di Lisa F, Schulz R, Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97: 583-586, 2005.
16. Hesketh CG, Shah MH, Halperin VL, Cooke CA, Akar FG, Yen TE, Kass DA, Machamer CE, Van Eyke JE, Tomaselli GF. Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res 106: 1153-1163, 2010.
17. Krieg T, Landsberger M, Alexeyev MF, Felix SB, Cohen MV, Downey JM. Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. Cardiovasc Res 58: 196-202, 2003.
18. Miro-Casas E, Ruiz-Meana M, Agullo E, Stahlhofen S, Rodríguez-Sinovas A, Cabestrero A, Jorge I, Torre I, Vazquez J, Boengler K, Schulz R, Heusch G, Garcia-Dorado D. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc Res 83: 747-756, 2009.
19. Miura T, Miki T. GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ J 73: 1184-1192, 2009.
20. Miura T, Miki T, Yano T. Role of the gap junction in ischemic preconditioning in the heart. Am J Physiol Heart Circ Physiol 298: H1115-H1125, 2010.
21. Miura T, Tanno M, Sato T. Mitochondrial kinase signaling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res 88: 7-15, 2010.
22. Nishihara M, Miura T, Miki T, Sakamoto J, Tanno M, Kobayashi H, Ikeda Y, Ohori K, Takahashi A, Shimamoto K. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3fj. Am J Physiol Heart Circ Physiol 291: H748-H755, 2006.
23. Ohori K, Miura T, Tanno M, Miki T, Sato T, Ishikawa S, Horio Y, Shimamoto K. Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am J Physiol Heart Circ Physiol 295: H2079-H2086, 2008.
24. Oldenburg O, Qin Q, Sharma AR, Cohen MV, Downey JM, Benoit JN. Acetylcholine leads to free radical production dependent on Katp channels, Gi proteins, phosphatidylinositol 3-kinase, and tyrosine kinase. Cardiovasc Res 55: 544-552, 2002.
25. Oldenburg O, Qin Q, Krieg T, Yang XM, Philipp S, Critz SD, Cohen MV, Downey JM. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 286: H468-H476, 2004.
26. Oudit GY, Penninger JM. Cardiac regulation by phosphoinositide 3-kinase and PTEN. Cardiovasc Res 82: 250-260, 2009.
27. Park SS, Zhao H, Jang Y, Mueller RA, Xu Z. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfu-sion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther 318: 124-131, 2006.
28. Park SS, Zhao H, Mueller RA, Xu Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 40: 708-716, 2006.
29. Rackauskas M, Kreuzberg MM, Pranevicius M, Willecke K, Verselis VK, Bukauskas FF. Gating properties of heterotypic gap junction channels formed of connexins 40, 43, and 45. Biophys J 92: 1952-1965, 2007.
30. Rottlaender D, Boengler K, Wolny M, Michels G, Endres-Becker J, Motloch LJ, Schwaiger A, Buechert A, Schulz R, Heusch G, Hoppe UC. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial Katp channels in mouse cardiomyocytes. J Clin Invest 120: 1441-1453, 2010.
31. Ruiz-Meana M, Rodríguez-Sinovas A, Cabestrero A, Boengler K, Heusch G, Garcia-Dorado D. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res 77: 325-33, 2008.
32. Sato M, Jiao Q, Honda T, Kurotani R, Toyota E, Okumura S, Takeya T, Minamisawa S, Lanier SM, Ishikawa Y. Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes. Role of Gβγ and connexin 43 (Cx43). J Biol Chem 284: 31431-31440, 2009.
33. Scemes E. Modulation of astrocytes P2Y1 receptors by the carboxyl terminal domain of the gap junction protein Cx43. Glia 56: 145-153, 2008.
34. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 419: 261-272, 2009.
35. Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilves-tre D, McVeigh ER, Tomaselli GF, Kass DA. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108: 929-932, 2003.
36. Suire S, Coadwell J, Ferguson J, Davidson K, Hawkins P, Stephens L. p84, a new Gβγ-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110-γ. Curr Biol 15: 566-570, 2005.
37. Suire S, Condliffe AM, Ferguson J, Ellson CD, Guillou H, Davidson K, Welch H, Caodwell J, Turner M, Chilvers ER Hawkins PT, Stephens L. Gβγ and the Ras binding domain of p110-γ are both important regulators of PI3Kg signaling in neutrophils. Nat Cell Biol 8: 1303-1309, 2006.
38. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phos-phatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90: 377-379, 2002.
39. Wang Y, Hill JA. Electrophysiological remodeling in heart failure. J Mol Cell Cardiol 48: 619-632, 2010.
40. Yin Z, Gao H, Wang H, Li L, Di C, Luan R, Tao L. Ischemic postconditioning protects both adult and aged Sprague Dawley rat hearts from ischemia/reperfusion injury through the PI3-K/Akt and GSK-3beta pathway. Clin Exp Pharmacol Physiol 36: 756-763, 2009.